Improved survival with rituximab-based chemoimmunotherapy in older patients with extranodal diffuse large B-cell lymphoma.

Olszewski, Adam J

Improved survival with rituximab-based chemoimmunotherapy in older patients with extranodal diffuse large B-cell lymphoma. [electronic resource] - Leukemia research Aug 2014 - 866-73 p. digital

Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.

1873-5835

10.1016/j.leukres.2014.04.009 doi


Aged
Aged, 80 and over
Antibodies, Monoclonal, Murine-Derived--administration & dosage
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Cyclophosphamide--therapeutic use
Doxorubicin--therapeutic use
Female
Humans
Immunotherapy--methods
Lymphoma, Large B-Cell, Diffuse--drug therapy
Male
Medicare
Prednisone--therapeutic use
Retrospective Studies
Rituximab
SEER Program
Survival Analysis
United States--epidemiology
Vincristine--therapeutic use